Lipella Pharmaceuticals I...

NASDAQ: LIPO · Real-Time Price · USD
0.64
0.00 (0.05%)
At close: Aug 15, 2025, 2:41 PM
0.64
0.00%
After-hours: Aug 15, 2025, 02:41 PM EDT

Lipella Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-1.31B -1.44M -1.44M -938.15K -1.19M -688.88K -1.32M -1.54M -1.07M -363.93K -713.77K -782.05K -737.95K -384.69K -524.62K -341.56K -614.6K
Depreciation & Amortization
722K 721.00 722.00 1.37K 72.00 723.00 962.00 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Stock-Based Compensation
n/a -668.73K 379.43K 80.67K 208.64K -1.36M 298.76K 847.62K 208.64K n/a 298.76K 213.49K 235.15K n/a 112.03K 211.62K 405.15K
Other Working Capital
n/a 441.13K 130.3K 53.44K -761.81K 41.77K -67.71K 168.22K -18.45K 95.66K -203.73K -12.07K -207.8K 27.96K 177.15K -152.59K 122.73K
Other Non-Cash Items
n/a 80.67K -3 -649 200.65K 1.35M 122.16K -5.39K 5.39K 2.7K 3.65K 1.64K 1.62K -55.33K 113.75K 213.32K 406.85K
Deferred Income Tax
n/a n/a n/a n/a n/a 962.00 -962 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
n/a 369.87K 411.39K -62.03K -605.99K -41.9K 213.29K 41.35K -224.2K 129.66K 91.14K -13.04K -198.24K -31.16K 259.96K -154.9K 123.7K
Operating Cash Flow
-1.43B -990.41K -653.1K -918.79K -1.39M -730.06K -689.36K -655.11K -1.08M -231.56K -320.21K -579.96K -699.43K -471.17K -150.92K -283.13K -84.05K
Capital Expenditures
n/a n/a n/a n/a n/a -14.42M -14.43K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a 300.85M n/a 300K -300K -300.55K n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 300.55K n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a -600.54K n/a 600.54K -300K -300.55K n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a n/a -14.42M -14.43K n/a n/a 300.25M n/a 600.54K -300K -300.55K n/a n/a n/a
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a -25K n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.89K n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 1.82M n/a n/a n/a 1.61M n/a -250K n/a 5.24M n/a n/a n/a n/a n/a n/a n/a
Financial Cash Flow
3.47B 1.82M 820.33K n/a 200K 1.61M -2.28K -250K -25K 5.24M -10 n/a n/a 2.25K -1.89K 638.96K 1.46M
Net Cash Flow
2.04B 831.13K 167.23K -918.79K -1.19M 883.89K -703.8K -905.11K -1.1M 5.01M -320.21K 20.58K -999.43K -769.47K -152.81K 355.83K 1.37M
Free Cash Flow
-1.43B -990.41K -653.1K -918.79K -1.39M -15.15M -703.8K -655.11K -1.08M -231.56K -320.21K -579.96K -699.43K -471.17K -150.92K -283.13K -84.05K